20.59
0.49%
0.10
Kiniksa Pharmaceuticals International Plc 주식(KNSA)의 최신 뉴스
Kiniksa Pharmaceuticals COO Tessari Eben sells shares worth $470k - Investing.com
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Acquired by Fmr LLC - Defense World
Kiniksa Pharmaceuticals CFO sells shares worth $593,997 By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals CFO sells shares worth $593,997 - Investing.com
Kiniksa Pharmaceuticals CFO sells shares worth $323,008 By Investing.com - Investing.com Canada
Kiniksa Pharmaceuticals CFO sells shares worth $323,008 - Investing.com India
KNSA (Kiniksa Pharmaceuticals International) Treasury Stock : $0.0 Mil (As of Sep. 2024) - GuruFocus.com
Kiniksa Pharmaceuticals officer sells $194k in stock By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals officer sells $194k in stock - Investing.com India
Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 - Marketscreener.com
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - Marketscreener.com
Principal Financial Group Inc. Sells 14,100 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World
Kiniksa Pharmaceuticals COO sells shares valued at $357,680 By Investing.com - Investing.com Nigeria
Kiniksa Pharmaceuticals COO sells shares valued at $357,680 - Investing.com India
HHLR Advisors, Ltd. Reduces Stake in Kiniksa Pharmaceuticals Int - GuruFocus.com
Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025? - Insider Monkey
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference 2024 | KNSA Stock News - StockTitan
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewswire
10 Top Performing European Stocks Heading into 2025 - Insider Monkey
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Kiniksa Pharmaceuticals International PLC (KNSA) Trading Down 3. - GuruFocus.com
Kiniksa Pharmaceuticals International, plc Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Yahoo Finance
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2024 Earnings Call Transcript - Insider Monkey
Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earning - GuruFocus.com
Kiniksa Pharmaceuticals International Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Kiniksa Pharmaceuticals Reports Strong Q3 2024 Growth - TipRanks
Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ... - Yahoo Finance
Kiniksa Pharm's Revenue Surges 67% in Q3 - The Motley Fool
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Gap Down to $24.04 on Oct 29 - GuruFocus.com
Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Kiniksa Pharmaceuticals Q3 2024 Earnings: EPS Miss, Revenue Beats Estimates with $112.2 Million - GuruFocus.com
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewswire
Exploring Kiniksa Pharmaceuticals's Earnings Expectations - Benzinga
What To Expect From Kiniksa Pharmaceuticals International PLC (K - GuruFocus.com
What To Expect From Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings - Yahoo Finance
Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning - GlobeNewswire
Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis - StockTitan
Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024 - GlobeNewswire
Kiniksa Pharmaceuticals COO Eben sells shares worth $456,790 - Investing.com India
Kiniksa Pharmaceuticals COO Eben sells shares worth $456,790 By Investing.com - Investing.com UK
High Growth Tech Stocks To Watch In October 2024 - Simply Wall St
What Makes Kiniksa Pharmaceuticals (KNSA) a Good Fit for 'Trend Investing' - Yahoo Finance
자본화:
|
볼륨(24시간):